|
1
|
Tsukamoto T, Nakata R, Tamura E, Kosuge Y,
Kariya A, Katsukawa M, Mishima S, Ito T, Iinuma M, Akao Y, et al:
Vaticanol C, a resveratrol tetramer, activates PPARalpha and
PPARbeta/delta in vitro and in vivo. Nutr Metab (Lond). 7:462010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jang M, Cai L, Udeani GO, Slowing KV,
Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta
RG, et al: Cancer chemopreventive activity of resveratrol, a
natural product derived from grapes. Science. 275:218–220. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Logan CY and Nusse R: The Wnt signaling
pathway in development and disease. Annu Rev Cell Dev Biol.
20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kawakita T, Masato N, Takiguchi E, Abe A
and Irahara M: Cytotoxic effects of 15-deoxy-Δ12,14-prostaglandin
J2 alone and in combination with dasatinib against uterine sarcoma
in vitro. Exp Ther Med. 13:2939–2945. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dai H, Deng HB, Wang YH and Guo JJ:
Resveratrol inhibits the growth of gastric cancer via the
Wnt/β-catenin pathway. Oncol Lett. 16:1579–1583. 2018.PubMed/NCBI
|
|
6
|
Cilibrasi C, Riva G, Romano G, Cadamuro M,
Bazzoni R, Butta V, Paoletta L, Dalprà L, Strazzabosco M, Lavitrano
M, et al: Resveratrol impairs glioma stem cells proliferation and
motility by modulating the Wnt signaling pathway. PLoS One.
12:e01698542017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vanamala J, Reddivari L, Radhakrishnan S
and Tarver C: Resveratrol suppresses IGF-1 induced human colon
cancer cell proliferation and elevates apoptosis via suppression of
IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer.
10:2382010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hope C, Planutis K, Planutiene M, Moyer
MP, Johal KS, Woo J, Santoso C, Hanson JA and Holcombe RF: Low
concentrations of resveratrol inhibit Wnt signal throughput in
colon-derived cells: Implications for colon cancer prevention. Mol
Nutr Food Res. 52 Suppl 1:S52–S61. 2008.PubMed/NCBI
|
|
9
|
Guastalla JP, Bachelot T and Ray-Coquard
I: Cyclooxygenase 2 and breast cancer. From biological concepts to
clinical trials. Bull Cancer. 91 (Suppl 2):S99–S108. 2004.(In
French).
|
|
10
|
Nguyen AV, Martinez M, Stamos MJ, Moyer
MP, Planutis K, Hope C and Holcombe RF: Results of a phase I pilot
clinical trial examining the effect of plant-derived resveratrol
and grape powder on Wnt pathway target gene expression in colonic
mucosa and colon cancer. Cancer Manag Res. 3:25–37. 2009.
|
|
11
|
Kahn M: Can we safely target the WNT
pathway? Nat Rev Drug Discov. 13:513–532. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kikuchi A: Tumor formation by genetic
mutations in the components of the Wnt signaling pathway. Cancer
Sci. 94:225–229. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yost C, Torres M, Miller JR, Huang E,
Kimelman D and Moon RT: The axis-inducing activity, stability, and
subcellular distribution of beta-catenin is regulated in Xenopus
embryos by glycogen synthase kinase 3. Genes Dev. 15:1443–1454.
1996. View Article : Google Scholar
|
|
14
|
Chen C, Zhao M, Tian A, Zhang X, Yao Z and
Ma X: Aberrant activation of Wnt/β-catenin signaling drives
proliferation of bone sarcoma cells. Oncotarget. 6:17570–17583.
2015.PubMed/NCBI
|
|
15
|
Zou Y, Yang J and Jiang D: Resveratrol
inhibits canonical Wnt signaling in human MG-63 osteosarcoma cells.
Mol Med Rep. 12:7221–7226. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Barker N and Clevers H: Mining the Wnt
pathway for cancer therapeutics. Nat Rev Drug Discov. 5:997–1014.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Frankel EN, Waterhouse AL and Kinsella JE:
Inhibition of human LDL oxidation by resveratrol. Lancet.
341:1103–1104. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mehlig K, Skoog I, Guo X, Schütze M,
Gustafson D, Waern M, Ostling S, Björkelund C and Lissner L:
Alcoholic beverages and incidence of dementia: 34-year follow-up of
the prospective population study of women in Goteborg. Am J
Epidemiol. 15:684–691. 2008.
|
|
19
|
Holcombe RF, Martinez M, Planutis K and
Planutiene M: Effects of a grape-supplemented diet on proliferation
and Wnt signaling in the colonic mucosa are greatest for those over
age 50 and with high arginine consumption. Nutr J. 14:622015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Boocock DJ, Faust GE, Patel KR, Schinas
AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher
AJ, et al: Phase I dose escalation pharmacokinetic study in healthy
volunteers of resveratrol, a potential cancer chemopreventive
agent. Cancer Epidemiol Biomarkers Prev. 16:1246–1252. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu C, Shin YG, Chow A, Li Y, Kosmeder JW,
Lee YS, Hirschelman WH, Pezzuto JM, Mehta RG and van Breemen RB:
Human, rat, and mouse metabolism of resveratrol. Pharm Res.
19:1907–1914. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu ML, Li H, Yu LJ, Chen XY, Kong QY, Song
X, Shu XH and Liu J: Short-term resveratrol exposure causes in
vitro and in vivo growth inhibition and apoptosis of bladder cancer
cells. PLoS One. 9:e898062014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Carter LG, D'Orazio JA and Pearson KJ:
Resveratrol and cancer: Focus on in vivo evidence. Endocr Relat
Cancer. 21:R209–R225. 2014. View Article : Google Scholar : PubMed/NCBI
|
